New Delhi, Mar 22 (PTI) The Central Drugs Standard Control Organization in consultation with Subject Expert Committee has approved four COVID-19 vaccines for restricted use in emergency situation for those aged below 18 years, the Rajya Sabha was informed on Tuesday.

The four vaccines which have been approved are Zydus Cadila's ZyCovD (in the age group of 12 years and older), Bharat Biotech's Covaxin (for >2 to <18 years age group), Biological E's Corbevax (for =5 to <18 years age group) and Serum Institute of India's Covovax (for >12 to <18 years age group), Minister of State for Health Bharati Pravin Pawar said in a written reply.

Also Read | Maharashtra Government Orders Temporary Stay on NA Tax Recovery From Housing Societies in Mumbai Suburbs.

The National COVID-19 vaccination programme was expanded to include adolescents aged 15 to 18 years from January 3, 2022. It was further expanded to children of age group 12 -14 years from March 16.

The National Covid vaccination programme is guided by National Technical Advisory Group on Immunization (NTAGI) and the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) which deliberate and consider scientific evidences related to prioritisation of beneficiaries and high risk group, if any, Pawar said.

Also Read | MSC Bank Recruitment 2022 for Treasury Specialized Officer Posts, Apply Online at mscbank.com.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)